| ¿µ¹® | liver function tests | ÇÑ±Û | °£±â´É°Ë»ç |
|---|---|---|---|
| ¼³¸í | Ç÷¾×°Ë»çÁß °¡Àå ¸¹ÀÌ ¾²ÀÌ´Â °Ë»ç¹ýÀ¸·Î ´ÙÀ½ 7°¡Áö¸¦ °Ë»çÇÏ°Ô µÈ´Ù. Ç÷ûÄÝ·¹½ºÅ×·Ñ, ÃѴܹéÁú, ¾ËºÎ¹Î, ºô¸®·çºó, GOT/GPT È¿¼Ò, ¾ËÄ®¸®ÀλêºÐÇØÈ¿¼Ò(alkaline phophatase) µîÀ» °Ë»çÇÏ°Ô µÇ´Â µ¥ °¢ °Ë»çÄ¡¿¡´Â ¸ðµÎ Àǹ̰¡ ÀÖÀ¸¸ç, ÀÌ °Ë»ç Çϳª·Î °£±â´ÉÀÇ Àü¹ÝÀûÀÎ »óÅ¿¡ ´ëÇØ¼ ¾Ë¾Æº¼ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | pulmonary function tests | ÇÑ±Û | Æó±â´É °Ë»ç |
|---|---|---|---|
| ¼³¸í | ¿©·¯ °¡Áö ±â±¸¸¦ ÀÌ¿ëÇØ Æó¿ëÀû ¹× ÇãÆÄÀÇ È®»ê´ÉÀ» ¾Ë¾Æº¸´Â °Ë»ç·Î ¸» ±×´ë·Î ÇãÆÄÀÇ ±â´ÉÀ» ÃøÁ¤ÇÏ´Â °Ë»çÀÌ´Ù. |
||
| ¿µ¹® | pregnancy | ÇÑ±Û | ÀӽŠ|
|---|---|---|---|
| ¼³¸í | Á¤ÀÚ¿Í ³ÀÚ°¡ ¼öÁ¤µÇ¾î »ý±ä ¹è¾Æ ȤÀº žƸ¦ ¿©ÀÚÀÇ Ã¼³»¿¡ Áö´Ï°í ÀÖ´Â »óÅ·ΠÀ̵éÀº Ãâ»ê Àü±îÁö °è¼Ó ¹ß´Þ°ú ¼ºÀåÀ» ÇÑ´Ù. |
||
| ¿µ¹® | toxemia of pregnancy | ÇÑ±Û | ÀÓ½ÅÁßµ¶Áõ |
|---|---|---|---|
| ¼³¸í | ÀÓ»êºÎ¿¡¼ ³ªÅ¸³ª´Â Ç÷°ü °úÀ×¹ÝÀÀ¼ºÀ¸·Î ÀÎÇÑ ÀϱºÀÇ Áõ»ó. °íÇ÷¾Ð, ´Ü¹é´¢, üÁßÁõ°¡¸¦ µ¿¹ÝÇÑ Àü½ÅÀû ºÎÁ¾ÀÌ 3´ë ÁÖÁõ»óÀÌ¸ç ½ÉÇÑ °æ¿ì °£Áú ¹ßÀÛÀ» º¸À̱⵵ ÇÑ´Ù. ÃÊ»êºÎ, ½ÖÅÂ¾Æ ÀӽŠµî¿¡¼ ÀÚÁÖ ³ªÅ¸³ª¸ç, ½ÉÇÑ °æ¿ì »ê¸ð¿Í ÅÂ¾Æ ¸ðµÎ À§ÇèÇÒ ¼ö ÀÖ´Ù. ±×¸®°í, ½ÉÇÑ °íÇ÷¾Ð°ú °£Áú ¹ßÀÛÀ¸·Î ÀÎÇÑ Å¾ÆÀÇ »ê¼Ò ºÎÁ·À» ¹æÁöÇϱâ À§ÇØ ±ä¹ÐÇÑ °¨½Ã¸¦ ¿äÇÑ´Ù. |
||
| ¿µ¹® | tubal pregnancy | ÇÑ±Û | ÀڱðüÀӽŠ|
|---|---|---|---|
| ¼³¸í | ³°ü³»¿¡ ÀÏ¾î³ ÀڱÿÜÀÓ½Å. ´ë°³ ÀÓ½ÅÀ» ³¡±îÁö Áö¼Ó½ÃŰÁö ¸øÇϰí À¯»êÇϰųª, ȤÀº º¹°³»·Î ÅÍÁ® ¸ñ¼ûÀÌ À§ÅÂ·Ó°Ô µÇ±âµµ ÇÑ´Ù. ºü¸¥ Áø´ÜÀ¸·Î ÀϾ ÇÕº´ÁõÀ» ¿¹¹æÇØ¾ß ÇÑ´Ù. |
||
| HCG, hCG | Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó 1. Placental Glycoprotein Hormone &nbs... |
|---|---|
| COG | center of gravity; cognitive function tests |
| ICU | infant care unit; immunologic contact urticaria; intensive care unit; intermediate care unit |
| OILD | occupational immunologic lung disease |
| RALT | routine admission laboratory tests |
| BPT | Bronchial provocation tests |
|---|---|
| CPT | Conjunctival provocation tests |
| IVGTT | I.v. glucose tolerance tests |
| IFT | Immunofluorescence tests |
| IDT | Intradermal tests |
| cytotoxicity tests, immunologic | The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitised lymphocyte, an antibody, or complement. (12 Dec 1998) |
|---|---|
| immunologic tests | Diagnostic techniques involving the demonstration or measurement of an immune response, including antibody production or assay, antigen-antibody reactions, serologic cross-reactivity, delayed hypersensitivity reactions, or heterogenetic responses. (12 Dec 1998) |
| immunologic pregnancy test | A general term for test's for detection of increased human chorionic gonadotropin in plasma or urine by immunologic techniques including latex particle agglutination, haemagglutination inhibition, radioimmunoassay, and radioreceptor assays. (05 Mar 2000) |
| pregnancy tests | Tests to determine whether or not an individual is pregnant. (12 Dec 1998) |
| adjuvants, immunologic | Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (freund's adjuvant, bcg, corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (12 Dec 1998) |
| receptors, immunologic | Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behaviour of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. (12 Dec 1998) |
| graft enhancement, immunologic | The induction of prolonged survival and growth of allografts of either tumours or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunised donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity. (12 Dec 1998) |
| monitoring, immunologic | Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumour antigen and other markers (often by radioimmunoassay), studies of cellular or humoral immunity in cancer aetiology, immunotherapy trials, etc. (12 Dec 1998) |
| contraception, immunologic | Contraceptive methods utilizing immunologic processes. (12 Dec 1998) |
| cytotoxicity, immunologic | The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitised T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. (12 Dec 1998) |
| suppressor factors, immunologic | Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility (I-j) and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory. (12 Dec 1998) |
| desensitization, immunologic | Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IgG, suppression of specific IgE, and an increase in suppressor T-cell activity. (12 Dec 1998) |
| dose-response relationship, immunologic | A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. (12 Dec 1998) |
| immunologic | <immunology> Pertaining to immunology. (18 Nov 1997) |
| immunologic and biological factors | A collective grouping for biologically active substances that play a role in the functioning of the immune system and those that show biological or physiological activity. (12 Dec 1998) |
Synonyms : Immunologic Pregnancy Test, Immunologic Pregnancy Tests, Immunological Pregnancy Tests, Pregnancy Test, Immunologic, Pregnancy Tests, Immunological, Test, Immunologic Pregnancy, Tests, Immunologic Pregnancy, Tests, Immunological Pregnancy
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|